Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections

JAS Ritsema; Hessel Weide; YM te Welscher; Wil Goessens; CF van Nostrum; G Storm; Irma Woudenberg; John Hays

doi:10.2217/fmb-2018-0194

Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections

JAS Ritsema, Hessel Weide, YM te Welscher, Wil Goessens, CF van Nostrum, G Storm, Irma Woudenberg, John Hays

Medical Microbiology & Infectious Diseases

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1683-1692
Number of pages	10
Journal	Future Microbiology
Volume	13
Issue number	15
DOIs	https://doi.org/10.2217/fmb-2018-0194
Publication status	Published - 2018

Research programs

EMC MM-04-28-01

Access to Document

10.2217/fmb-2018-0194

http://hdl.handle.net/1765/113088

Cite this

@article{f57238c00c264a0c9f378792f41872a6,

title = "Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections",

author = "JAS Ritsema and Hessel Weide and {te Welscher}, YM and Wil Goessens and {van Nostrum}, CF and G Storm and Irma Woudenberg and John Hays",

year = "2018",

doi = "10.2217/fmb-2018-0194",

language = "Undefined/Unknown",

volume = "13",

pages = "1683--1692",

journal = "Future Microbiology",

issn = "1746-0913",

publisher = "Taylor & Francis Ltd",

number = "15",

}

TY - JOUR

T1 - Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections

AU - Ritsema, JAS

AU - Weide, Hessel

AU - te Welscher, YM

AU - Goessens, Wil

AU - van Nostrum, CF

AU - Storm, G

AU - Woudenberg, Irma

AU - Hays, John

PY - 2018

Y1 - 2018

U2 - 10.2217/fmb-2018-0194

DO - 10.2217/fmb-2018-0194

M3 - Article

C2 - 30499686

SN - 1746-0913

VL - 13

SP - 1683

EP - 1692

JO - Future Microbiology

JF - Future Microbiology

IS - 15

ER -